Laboratorios Farmaceuticos Rovi's total assets for Q3 2025 were €922.07M, an increase of 6.03% from the previous quarter. ES:ROVI total liabilities were €289.27M for the fiscal quarter, a -1.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.